Key Takeaways Zoetis gained CVMP support for Lenivia, a monoclonal antibody for canine OA pain relief.Lenivia offers up to 3 months of pain relief with one jab and was well-tolerated in clinical studies.Lenivia will complement Librela, giving vets and owners both monthly and quarterly OA pain therapy options.Zoetis (ZTS) announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) has issued a positive opinion for its investigational monoclonal antibody (mAb) therapy, Le ...